Advanced Oncotherapy 26p £64m (.AVOL) Has raised £14.9m at 25p. All critical components delivered to Daresbury; funding will progress assembly and validation of first LIGHT system. Documentation work for LIGHT continues despite site closures due to COVID-19.The Company was already working to a tight deadline to bring the LIGHT System into operation by the end of 2020. It now believes that the closure of these facilities will delay this objective and first patient treatment into 2021. In the meantime, the core team of the Company has shifted to focussing on finalising the documentation required for the LIGHT System to gain regulatory approval. #AVO
Login or register to post comments